These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8998276

  • 1. Regulation of [3H] dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors.
    Weatherspoon JK, Gonzalez-Alvear GM, Frank AR, Werling LL.
    Schizophr Res; 1996 Jul; 21(1):51-62. PubMed ID: 8998276
    [Abstract] [Full Text] [Related]

  • 2. Release of [3H]dopamine from guinea pig striatal slices is modulated by sigma1 receptor agonists.
    Gonzalez GM, Werling LL.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):455-61. PubMed ID: 9349631
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y-mediated enhancement of NMDA-stimulated [3H]dopamine release from rat prefrontal cortex is reversed by sigma1 receptor antagonists.
    Ault DT, Werling LL.
    Schizophr Res; 1998 May 04; 31(1):27-36. PubMed ID: 9633834
    [Abstract] [Full Text] [Related]

  • 4. sigma1 Receptors in rat striatum regulate NMDA-stimulated [3H]dopamine release via a presynaptic mechanism.
    Gonzalez-Alvear GM, Werling LL.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):713-9. PubMed ID: 8750737
    [Abstract] [Full Text] [Related]

  • 5. Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors.
    Ault DT, Werling LL.
    Eur J Pharmacol; 1999 Dec 15; 386(2-3):145-53. PubMed ID: 10618464
    [Abstract] [Full Text] [Related]

  • 6. Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.
    Ault DT, Werling LL.
    Brain Res; 1997 Jun 20; 760(1-2):210-7. PubMed ID: 9237537
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
    Izenwasser S, Thompson-Montgomery D, Deben SE, Chowdhury IN, Werling LL.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):189-96. PubMed ID: 9652359
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP, de Costa BR, Bowen WD.
    Br J Pharmacol; 1996 Sep 10; 119(1):65-72. PubMed ID: 8872358
    [Abstract] [Full Text] [Related]

  • 10. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B, Debonnel G.
    Eur J Pharmacol; 1999 Mar 05; 368(2-3):183-96. PubMed ID: 10193654
    [Abstract] [Full Text] [Related]

  • 11. Neurotensin, N-acetyl-aspartylglutamate and beta-endorphin modulate [3H]dopamine release from guinea pig nucleus accumbens, prefrontal cortex and caudate-putamen.
    Weatherspoon JK, Frank AR, Werling LL.
    Neuropeptides; 1996 Oct 05; 30(5):497-505. PubMed ID: 8923514
    [Abstract] [Full Text] [Related]

  • 12. Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.
    Ault DT, Radeff JM, Werling LL.
    J Pharmacol Exp Ther; 1998 Feb 05; 284(2):553-60. PubMed ID: 9454797
    [Abstract] [Full Text] [Related]

  • 13. Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands.
    Gonzalez-Alvear GM, Werling LL.
    J Pharmacol Exp Ther; 1994 Oct 05; 271(1):212-9. PubMed ID: 7965717
    [Abstract] [Full Text] [Related]

  • 14. Functional and binding properties of sigma receptors in rat cerebellum.
    Gonzalez-Alvear GM, Thompson-Montgomery D, Deben SE, Werling LL.
    J Neurochem; 1995 Dec 05; 65(6):2509-16. PubMed ID: 7595545
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY.
    Psychopharmacology (Berl); 2005 Dec 05; 183(2):144-53. PubMed ID: 16220333
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Bonaccorso S, Meltzer HY, Li Z, Dai J, Alboszta AR, Ichikawa J.
    Neuropsychopharmacology; 2002 Sep 05; 27(3):430-41. PubMed ID: 12225700
    [Abstract] [Full Text] [Related]

  • 19. Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites.
    Chaki S, Okuyama S, Ogawa S, Tomisawa K.
    Neurochem Int; 1998 Jul 05; 33(1):29-34. PubMed ID: 9694039
    [Abstract] [Full Text] [Related]

  • 20. SH-SY5Y cells as a model for sigma receptor regulation of potassium-stimulated dopamine release.
    Ault DT, Werling LL.
    Brain Res; 2000 Sep 22; 877(2):354-60. PubMed ID: 10986350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.